Matthews South

Matthews South

  • About Us
  • Our Solutions
    • Debt
    • Equity
    • IPO
    • Pre-IPO Financing
    • Convertible & Call Spread
      • Call Spread Unwind
      • Liability Management
    • Share Repurchases
      • Accelerated Share Repurchase (ASR)
      • Enhanced Open Market Repurchase (eOMR)
    • Capital Structure Review
  • Our Clients
    • Client List
    • Testimonials
  • Our Team
  • Video Library
  • Blog
  • Contact Us
  • Login

OUR BLOG

Convertible Issuance in Life Sciences: How, When and Why

by Kristina Woodhouse | June 22, 2022 | Biotech, Convertible, Financing, Healthcare, Post-IPO

In the first installment of our three-part series on the financing landscape for life sciences issuers, we covered the evolution of the typical life sciences IPO.  In the second installment, we covered post-IPO financing dynamics and the importance of laying the foundation for successful capital ... >>>Read More

Post-IPO Financing Dynamics: How to Lay the Foundation for Successful Capital Raises

by Kristina Woodhouse | May 19, 2022 | Biotech, Equity, Financing, Healthcare, IPO, IPO Advisory, Post-IPO

In the first installment of our three-part series on the financing landscape for life sciences issuers, we covered the evolution of the typical life sciences IPO.  In this second installment, we will cover post-IPO financing dynamics and the importance of laying the foundation for successful capital ... >>>Read More

What You Need to Know as You Navigate the Market and an Ever-Evolving Life Sciences Financing Landscape

by Brian Hagerty | January 19, 2022 | Biotech, Crossover, Equity, Financing, Healthcare, IPO, IPO Advisory, Pre-IPO

The financing landscape for life sciences issuers has transformed over the last 5 years.  In this three-part series, we will cover 1) the evolution of the typical life sciences IPO, 2) post-IPO financing dynamics and the importance of laying the foundation for successful capital raises, and 3) later ... >>>Read More

Post-SPAC Warrant Redemption Features (Part 3)

by Jared Kramer | December 21, 2021 | Pre-IPO, SPAC

This is the third of a series of posts examining the redemption features of warrants in post-SPAC public companies.  In the first post, we described typical redemption features in warrants.  The second post discussed how issuers might economically analyze whether and when to redeem the warrants. ... >>>Read More

Post-SPAC Warrant Redemption Features (Part 2)

by Jared Kramer | October 5, 2021 | Pre-IPO, SPAC

This is the second of a three-part series of posts examining the redemption features of warrants in post-SPAC public companies.  In the first post, we described typical redemption features in warrants.  Here we introduce economic frameworks for how issuers can approach the decision whether and when ... >>>Read More

  • 1
  • 2
  • Next Page »

Categories

  • ASR
  • Biotech
  • Buyback
  • Convertible
  • COVID-19
  • Crossover
  • eOMR
  • Equity
  • Financing
  • Healthcare
  • IPO
  • IPO Advisory
  • Market Review
  • OMR
  • Post-IPO
  • Pre-IPO
  • Software
  • SPAC

Archives

Recent Posts

  • Update: Convertible Settlement Method Structuring after New Accounting Standards
  • Early Read: No Meaningful Impact in Q1 from 1% Tax on Stock Buybacks
  • Managing Debt in an Uncertain Environment – Assessing a Cash Repurchase
  • Q1 2023 Convertible Market Review
  • Apples and Oranges: Calculating and Comparing Repurchase Prices Is More Interesting than You Think

Contact Us

To learn more about our solutions or to schedule a demo of our software, please contact us by filling out the form below, or email us at info@matthewssouth.com.






    • Matthews South LLC is a member of FINRA and SIPC
    • Brokercheck
    • © Matthews South, Inc. 2022
    • Privacy Policy
    • Additional Disclosure
    • Testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success